Literature DB >> 2460403

Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.

F Dromer1, P Yeni, J Charreire.   

Abstract

Cryptococcus neoformans is responsible for opportunistic infections in patients with cellular immune defects. However, C. neoformans-specific capsular polysaccharide antibodies have been shown to participate in host defenses during cryptococcosis. We investigated the humoral response after primary immunization in various inbred strains of mice and the genetic control. Our data strengthen the arguments for the T-independent type-2 nature of cryptococcal antigen, since CBA/N mice were unable to produce specific antibodies. They show that the influence of the genetic background is predominant for the good response with at least four independent autosomal genes governing this response, including an Igh control as reported for other polysaccharides. Immunization of intra-H-2 recombinant mice on a B10 background allowed us to identify a major histocompatibility complex control located in the subregion E alpha. The genetic control of antibody production following immunization with cryptococcal polysaccharide might explain the high variability of humoral responses during cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460403     DOI: 10.1007/bf00355373

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  45 in total

1.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

2.  Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.

Authors:  R Cherniak; E Reiss; M E Slodki; R D Plattner; S O Blumer
Journal:  Mol Immunol       Date:  1980-08       Impact factor: 4.407

3.  Differences in antigen handling by peritoneal macrophages from the Biozzi high and low responder lines of mice.

Authors:  E Wiener; A Bandieri
Journal:  Eur J Immunol       Date:  1974-07       Impact factor: 5.532

4.  Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype.

Authors:  R Riblet; B Blomberg; M Weigert; R Lieberman; B A Taylor; M Potter
Journal:  Eur J Immunol       Date:  1975-11       Impact factor: 5.532

5.  Murine primary in vivo response to TNP-Ficoll: multigenic control involving H-2.

Authors:  M A Le Moal; J L Guénet; P Truffa-Bachi
Journal:  Ann Inst Pasteur Immunol (1985)       Date:  1986 May-Jun

6.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  The immune response to bacterial dextrans. I. Genetic control of responsiveness.

Authors:  F Ivars; D Holmberg; A Coutinho
Journal:  Scand J Immunol       Date:  1983-05       Impact factor: 3.487

8.  Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation.

Authors:  J R Graybill; L Mitchell; D J Drutz
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

9.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Regulation of the antibody response to type III pneumococcal polysaccharide by contrasuppressor T cells.

Authors:  H Braley-Mullen
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  19 in total

1.  Antibody response to Cryptococcus neoformans proteins in rodents and humans.

Authors:  L C Chen; D L Goldman; T L Doering; L a Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes.

Authors:  F Dromer; J Barbet; J Bolard; J Charreire; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.

Authors:  G Nussbaum; S Anandasabapathy; J Mukherjee; M Fan; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.

Authors:  Johanna Rivera; Oscar Zaragoza; Arturo Casadevall
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 5.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Authors:  Robert W Maitta; Kausik Datta; Qing Chang; Robin X Luo; Bradley Witover; Krishanthi Subramaniam; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.

Authors:  S L Zebedee; R K Koduri; J Mukherjee; S Mukherjee; S Lee; D F Sauer; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

8.  Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice.

Authors:  Erin E McClelland; Donald L Granger; Wayne K Potts
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.

Authors:  J B Sundstrom; R Cherniak
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.